pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4665 |
Genomic Coordinates | chr9: 6007826 - 6007904 |
Description | Homo sapiens miR-4665 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4665-5p | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 10| CUGGGGGACGCGUGAGCGCGAGC |32 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DDA1 | ||||||||||||||||||||
Synonyms | C19orf58, PCIA1 | ||||||||||||||||||||
Description | DET1 and DDB1 associated 1 | ||||||||||||||||||||
Transcript | NM_024050 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DDA1 | |||||||||||||||||||||
3'UTR of DDA1 (miRNA target sites are highlighted) |
>DDA1|NM_024050|3'UTR 1 GACTCTCAACTCCACAGGCGCCTCCTGCCAGGTCTGCTCCTCGGTCGCCCACCCGCCTGCCCGCCATGTGTAAGCACCCC 81 GCCCGCCCGCCTCCCTGCCGGCCCATCCACACCCTGCGTCCACACCACTTCCAACCTCATAGGAGCCGATGTATTTATTT 161 TCCTTGAGTTTTTATTTATGCTGTAACCTGTATCAAGCGTTGGTTAAAGGGGACATCAGACCCAGTAGTGTGATGTTGGT 241 AGATGCTTTTTAAAAAAAACAACATTGTCCCCCCGACCCCCGCCTTCCATCGGGCCAGTTCCCCGATTCCTGCCCCCAGT 321 TCTCCAGAGAACCAGAGTGTGTCTGTGAGAGTCTCTAGCGGGGGCTTTACTGTGGCCGGGCGACAGGGGCGGGCCCGGGG 401 TGGCCTGACCTACCAGGACAGCCGAGTGGCCTTCTCCCCCCCAACACCGGTCCAGGCCATTGAGACTCGGTCTTGTCCCA 481 CGCTTCGCCCGGAACTTTCCCATGCCCAGGCCTCACTCAGCGTGCACGCACGTTGGGGAGAAGTCGGCCCTTGGGATCTT 561 TCTCTTGAGTCATTTTATTTTTATCATGGACTAGTGCGTGCTCCGTGTCCACCCCAATAAAAGGGTCTTTCCTACTTGAC 641 CTCGCGTCTTTGCTCCACACACCTTGGCTGCAGAGGACGGAGCCCCTGGGAGTCATCCCTGTTGTCACCAAGAGGAGTGA 721 GAAGGGCCCCCCACGCCAGGGGCCCCAGGACCGGCTGGATTCTCTCGTGGGCTTGCTGAGGCCACCATGTTCAAGGCCAA 801 GACCTGCCTGGACCATCCCCTCTGCCTCTCCTGTCAAGGTGACCCCAAGGACAGGTCATTCCTGAGAGACGGTCCATGGT 881 GCCAAGGATGGAGCGGGGTCAGCCCCCTGCCTGGGATACCGCCAAGCAGGGCAGCGCACCTGTCAGACACCGCAGAGATG 961 GCCGGCCTCATCCGGGGGCCTGGGGTCTCTGGCCTCTGCTGCTCCCCTGAGGCATGGTGACAGTACAGACGGCATCTGGC 1041 CGGTCTTGCTGTCCTAGGTGGTGGCCTCACCCTTGCTGGGTCATAGAGGAGCTGTACAGAAGGTTGGCACCTGGCAGTTG 1121 GCATGTGCCATGGCCGCTCATGGGGACCCCTCTTCCGCCAGCTGGGCTGGGTTTGGGGCTGAGCTTGGGTATGTAGGGGT 1201 GTTCGGGCTCTGGGCAGAAGGTTTGTGGCCCTGACCACTGAGCCTGGGGCTGGGGGAACACCGCTTCTCCCCTTATTGCC 1281 CCCACTGGTGGTGGTGGGGATCTCAGTTTTCTTTTGTTTTGTTTTGTTTGTTTGTTTGAGTTGGGGTCTTGTACTCTTTC 1361 CCAGGCTGGAGTGCAGTGGCGTAATCACAGCTCACTGCAGCCTCGACCTCAAGCCTTCCTCCCACCTCAGCCTTCCAAGC 1441 CGCTGGGACCACAGGCACCCACCACCATGCCTGGCTAATTTTTTTTTTTTTTTGAGATGGAGTCTCGCTGTGTCTCCCAG 1521 GCTGGAGTGCAGTGGCAAGATCTCAGCTCACTACAACCTCTGCCTCCCAGGTTCAAGTGATTCTCCTACCTCAGCCTCCT 1601 GAGTAGCTGGGATTACACGCGTGCGCCCCTACACCCAGCTAATTTTTCTATTTTTAGTGGAGACGGCGTTTTGTCATGTT 1681 GGCCAGGCTGGTCTCGAACTCCTGACCTCAGGTGCTTCGCCTGCCTCGGCCTCCCAAAGTGCTGTGACCGCACCTGGCTG 1761 CCTGGCTAATATTTTAAAAATTTTTTGTAGAGACAGGGTTTCACCATGTTGCCCAGGCTGGTCTCAAACTCCTGGGCTCA 1841 AGTCATCCACCTTCCTCAGCCTCCCAAAGTGCTGGGGTTACAGACGTGAACCACCGTGCCTGGCAGAGGTCTCTGTTTTG 1921 AGAGCTGAGTCTGAGGGCGTTGGGATGGTGTAGGGTTGGGCCACAGAGCTAGCAGACACTCCGGGCTATGGAGGGTCCGC 2001 CTGCCCCAGATTCCACTGTGGAGGGCCCTGCCTGTGTCAGACCCTCGGGCCTAGGCGGCCCATCTCTCCCAAGGACGGAG 2081 AGTGCCAGGGTGGGCTCCCGTCCTACACAAGGAGTGGCTGACCAGGCCCAGGCACAGCACAGCCACCCTGCTGTACCTCC 2161 CAGCTCCCGGCAGTGTCTACACCACAGTGATGGTGCTACAGGGGCCATGTGGTCACAGGACAGGTGGTCAGGAAATGCAC 2241 ACTTGACTGCGGTCGATGGTGCCGGGTCCGGCTGAATGCCCTGGAGGCTCCCAGGCCAGCTGGGGAGTCCCAGTCCCCAG 2321 GGTTGGTGTGACCTGGGCAGGCCTGCGGTGTCCATCTGTGAATGACTGAGATGGTGGGACTTCAGCTTCCAAGGCCAGGG 2401 GCCAGAGTGGGAGCAGGGGGCACTCCCGCCTTTCCCCTCGGCCTGTCTAGACCTCTCTGGCTCCCAGTTTCTGCTTTGAG 2481 TGGCTGGGGGCTGTCTCCTGCCTGTGCTGTCTGCCCGTCGCTCTGCAGGGCTGCTGGGCGGGCACCTCCTTCCCCTCCCC 2561 TACCTCAGCTCCCTCCTTTGGGGTCTGAGGGCTGTGCCCCAGCTTGCCTCCCTGTGGCCTCCCCCTAGAACCCCTGGGTC 2641 TGTCGGGACATGCCCCACCTGGCACACACACCCTGTGTAGCTCCCACTGCCTGTGGGAGGACGCTGGGCCCCTGAGCCGG 2721 CCTCTGTCTACCCCTCCTGCCTTTGGGGTCCCCTTTACCCCACTGTTCCCCCAAACTGCCTTCCACCTTCTCCGCCTTTG 2801 CACAGGCTGTTCTCCTGCCTCCAGTGAACTCTGACTTCTCCACAGCCTCCCAAAGGGCCCCTTGCTCACACTGGCCCAGC 2881 CCTGCAGCATGGCCATGTTGGTCTCTGAGCCTTAAGCCTTTGGATGTGGACACATTTGTCCTCTTCCTGAAAAATGTGAG 2961 GGTCTGAGAGGCCACGTTCCTGTTCCTGAGTCATACGACAGAGTCCCAGTGACTTGGGTCTGATGTCTGTCCCACAGTGG 3041 GACATCCCTGCTGCATCCCAATGCCACCCCGTGTCCTGGGGACACCCAAATGTGCCATTCTCTCAGTATCACAAGTCGGG 3121 GACTGCAGGAGGCTCAGGTGCCAGGTGCCTTCTGATGTTCATGCCACAAGCTCTTCCCACTGTCTCTGGCTCCCCAGACG 3201 ATGTTCCAGGAGGCGGGTGTGCCAGAAGGGGCCACGTCTTGCAAACCACCGCGCTGTCCTCTTTGAGAAGGAGTCTTACT 3281 CAGGACTGGGGCCTGTGCACACATTGTCGCCTCTTTTCAGCACTTAGAGATTCCTTCCTTTGTCTAGTGGCTGAAGCCAG 3361 GGCTGAAGTTGGCCTCCAAATCTGGGCCGTCTCAGAGGCGGCGCAGCCTGGAGTTTTCCATCTGTGGCCAAGACCCAGTT 3441 TTTGGGAGGAGGCCCTCATGGGTCAAGCCAGCCTGTACCAGGATGGGGGGAGGGGGTTCCCAACCTAGGCCCCAGCCACC 3521 CAGACTCCCCCACCCCCACTCCCTTTTCCACTGCTCTGACCTCGGGCACTGTTGAAATATAGTTTTTATTGCATTTCTGC 3601 CGTTTTACAAAAATATGACAAAATAAATTAAAAACAAATAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000359866.4 | 3UTR | ACUCCCCCACCCCCACUCCCUUUUCCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
123 hsa-miR-4665-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT115350 | IGF1R | insulin like growth factor 1 receptor | 2 | 8 | ||||||||
MIRT144387 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT145421 | ANKRD13B | ankyrin repeat domain 13B | 2 | 4 | ||||||||
MIRT146684 | MINK1 | misshapen like kinase 1 | 2 | 2 | ||||||||
MIRT178944 | C11ORF57 | chromosome 11 open reading frame 57 | 2 | 2 | ||||||||
MIRT189772 | CDADC1 | cytidine and dCMP deaminase domain containing 1 | 2 | 2 | ||||||||
MIRT238514 | HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B | 2 | 2 | ||||||||
MIRT366308 | GDI1 | GDP dissociation inhibitor 1 | 2 | 4 | ||||||||
MIRT375173 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT442321 | WNT9B | Wnt family member 9B | 2 | 2 | ||||||||
MIRT442581 | HOXD9 | homeobox D9 | 2 | 2 | ||||||||
MIRT451170 | PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 2 | 2 | ||||||||
MIRT451894 | ILK | integrin linked kinase | 2 | 2 | ||||||||
MIRT453620 | SLC4A2 | solute carrier family 4 member 2 | 2 | 2 | ||||||||
MIRT454769 | STOML3 | stomatin like 3 | 2 | 2 | ||||||||
MIRT455038 | MEN1 | menin 1 | 2 | 2 | ||||||||
MIRT455151 | SUV39H1 | suppressor of variegation 3-9 homolog 1 | 2 | 2 | ||||||||
MIRT456891 | DDA1 | DET1 and DDB1 associated 1 | 2 | 2 | ||||||||
MIRT457201 | THSD4 | thrombospondin type 1 domain containing 4 | 2 | 2 | ||||||||
MIRT457373 | CAMK2A | calcium/calmodulin dependent protein kinase II alpha | 2 | 2 | ||||||||
MIRT459190 | RCE1 | Ras converting CAAX endopeptidase 1 | 2 | 2 | ||||||||
MIRT462580 | MYL12A | myosin light chain 12A | 2 | 2 | ||||||||
MIRT464669 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT464753 | UBE2N | ubiquitin conjugating enzyme E2 N | 2 | 2 | ||||||||
MIRT464881 | UBALD1 | UBA like domain containing 1 | 2 | 2 | ||||||||
MIRT465932 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT466013 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT466905 | STK38 | serine/threonine kinase 38 | 2 | 10 | ||||||||
MIRT468421 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT468592 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT468853 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT468900 | RPS6KA4 | ribosomal protein S6 kinase A4 | 2 | 2 | ||||||||
MIRT469189 | RICTOR | RPTOR independent companion of MTOR complex 2 | 2 | 2 | ||||||||
MIRT469305 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | 2 | 2 | ||||||||
MIRT469771 | RAB15 | RAB15, member RAS oncogene family | 2 | 2 | ||||||||
MIRT469934 | PTPRF | protein tyrosine phosphatase, receptor type F | 2 | 2 | ||||||||
MIRT470000 | PTPLB | 3-hydroxyacyl-CoA dehydratase 2 | 1 | 1 | ||||||||
MIRT470585 | POTEM | POTE ankyrin domain family member M | 2 | 2 | ||||||||
MIRT470615 | POTEG | POTE ankyrin domain family member G | 2 | 2 | ||||||||
MIRT470932 | PKM | pyruvate kinase, muscle | 2 | 2 | ||||||||
MIRT472511 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT472843 | MTHFR | methylenetetrahydrofolate reductase | 2 | 2 | ||||||||
MIRT473298 | MEX3A | mex-3 RNA binding family member A | 2 | 2 | ||||||||
MIRT473951 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT474336 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT474399 | KLHL28 | kelch like family member 28 | 2 | 8 | ||||||||
MIRT476487 | GATAD2A | GATA zinc finger domain containing 2A | 2 | 2 | ||||||||
MIRT477597 | EFNA3 | ephrin A3 | 2 | 2 | ||||||||
MIRT477857 | DYRK2 | dual specificity tyrosine phosphorylation regulated kinase 2 | 2 | 2 | ||||||||
MIRT479858 | CCDC6 | coiled-coil domain containing 6 | 2 | 2 | ||||||||
MIRT480123 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT480391 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 2 | ||||||||
MIRT480685 | BRPF1 | bromodomain and PHD finger containing 1 | 2 | 2 | ||||||||
MIRT482326 | AGO2 | argonaute 2, RISC catalytic component | 2 | 2 | ||||||||
MIRT482513 | ACTB | actin beta | 2 | 2 | ||||||||
MIRT483244 | CITED4 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4 | 2 | 4 | ||||||||
MIRT483282 | SLC35C2 | solute carrier family 35 member C2 | 2 | 4 | ||||||||
MIRT483381 | SPATA6 | spermatogenesis associated 6 | 2 | 4 | ||||||||
MIRT483416 | RHOXF2B | Rhox homeobox family member 2B | 2 | 2 | ||||||||
MIRT483468 | STMN3 | stathmin 3 | 2 | 4 | ||||||||
MIRT484178 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 2 | ||||||||
MIRT484460 | DDX6 | DEAD-box helicase 6 | 2 | 2 | ||||||||
MIRT484515 | POLD3 | DNA polymerase delta 3, accessory subunit | 2 | 2 | ||||||||
MIRT484595 | SIX3 | SIX homeobox 3 | 2 | 6 | ||||||||
MIRT484738 | ABCC6 | ATP binding cassette subfamily C member 6 | 2 | 4 | ||||||||
MIRT485248 | PLEKHA3 | pleckstrin homology domain containing A3 | 2 | 2 | ||||||||
MIRT485592 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | 2 | 4 | ||||||||
MIRT485912 | PGPEP1 | pyroglutamyl-peptidase I | 2 | 4 | ||||||||
MIRT485954 | RTBDN | retbindin | 2 | 2 | ||||||||
MIRT486597 | METTL6 | methyltransferase like 6 | 2 | 2 | ||||||||
MIRT486807 | NDOR1 | NADPH dependent diflavin oxidoreductase 1 | 2 | 2 | ||||||||
MIRT486972 | STEAP3 | STEAP3 metalloreductase | 2 | 4 | ||||||||
MIRT487364 | C10orf54 | V-set immunoregulatory receptor | 2 | 2 | ||||||||
MIRT488072 | DLGAP3 | DLG associated protein 3 | 2 | 4 | ||||||||
MIRT488150 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT488454 | B3GALNT2 | beta-1,3-N-acetylgalactosaminyltransferase 2 | 2 | 2 | ||||||||
MIRT489027 | PRPF4B | pre-mRNA processing factor 4B | 2 | 2 | ||||||||
MIRT489704 | CALML3 | calmodulin like 3 | 2 | 2 | ||||||||
MIRT489757 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | 2 | 2 | ||||||||
MIRT490015 | PIEZO1 | piezo type mechanosensitive ion channel component 1 | 2 | 2 | ||||||||
MIRT490120 | FN3K | fructosamine 3 kinase | 2 | 2 | ||||||||
MIRT490187 | PKNOX2 | PBX/knotted 1 homeobox 2 | 2 | 2 | ||||||||
MIRT490313 | ANK1 | ankyrin 1 | 2 | 4 | ||||||||
MIRT490595 | SLC47A1 | solute carrier family 47 member 1 | 2 | 4 | ||||||||
MIRT491133 | GRWD1 | glutamate rich WD repeat containing 1 | 2 | 2 | ||||||||
MIRT493027 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | 2 | 2 | ||||||||
MIRT494199 | CLIP2 | CAP-Gly domain containing linker protein 2 | 2 | 2 | ||||||||
MIRT495699 | PADI1 | peptidyl arginine deiminase 1 | 2 | 2 | ||||||||
MIRT501149 | SLC10A7 | solute carrier family 10 member 7 | 2 | 6 | ||||||||
MIRT501413 | RAB11FIP4 | RAB11 family interacting protein 4 | 2 | 2 | ||||||||
MIRT501638 | PHLDA3 | pleckstrin homology like domain family A member 3 | 2 | 2 | ||||||||
MIRT512047 | DIRAS2 | DIRAS family GTPase 2 | 2 | 4 | ||||||||
MIRT519877 | ZFP30 | ZFP30 zinc finger protein | 2 | 4 | ||||||||
MIRT522598 | MAP7D1 | MAP7 domain containing 1 | 2 | 4 | ||||||||
MIRT524787 | BAG5 | BCL2 associated athanogene 5 | 2 | 2 | ||||||||
MIRT539158 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT555901 | ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | 2 | 2 | ||||||||
MIRT562543 | CCDC71L | coiled-coil domain containing 71 like | 2 | 4 | ||||||||
MIRT568791 | VPS37D | VPS37D, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT569568 | PRELP | proline and arginine rich end leucine rich repeat protein | 2 | 2 | ||||||||
MIRT570000 | COL1A2 | collagen type I alpha 2 chain | 2 | 2 | ||||||||
MIRT570183 | RAP1GAP2 | RAP1 GTPase activating protein 2 | 2 | 2 | ||||||||
MIRT572990 | RPP25 | ribonuclease P and MRP subunit p25 | 2 | 2 | ||||||||
MIRT574618 | LPCAT3 | lysophosphatidylcholine acyltransferase 3 | 2 | 2 | ||||||||
MIRT615354 | CCNF | cyclin F | 2 | 2 | ||||||||
MIRT616091 | HOXB5 | homeobox B5 | 2 | 2 | ||||||||
MIRT617658 | RSRC1 | arginine and serine rich coiled-coil 1 | 2 | 2 | ||||||||
MIRT619107 | CD40LG | CD40 ligand | 2 | 2 | ||||||||
MIRT621198 | ARPC1B | actin related protein 2/3 complex subunit 1B | 2 | 2 | ||||||||
MIRT628839 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT635552 | LEPREL1 | prolyl 3-hydroxylase 2 | 2 | 2 | ||||||||
MIRT635703 | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 | 2 | 2 | ||||||||
MIRT646646 | FNBP1 | formin binding protein 1 | 2 | 2 | ||||||||
MIRT654905 | POMGNT1 | protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | 2 | 2 | ||||||||
MIRT655121 | PHF7 | PHD finger protein 7 | 2 | 2 | ||||||||
MIRT659457 | CLPB | ClpB homolog, mitochondrial AAA ATPase chaperonin | 2 | 4 | ||||||||
MIRT668952 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT684242 | TBXA2R | thromboxane A2 receptor | 2 | 2 | ||||||||
MIRT692701 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT694328 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT712137 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT713672 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT715741 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|